Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Phreesia, Inc. (NYSE: PHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents help investors analyze how Phreesia reports its financial performance, material events and key agreements related to its healthcare technology and patient activation business.
Phreesia’s filings include Current Reports on Form 8-K that describe significant developments such as quarterly financial results, material definitive agreements and acquisitions. For example, the company has filed 8-Ks covering its fiscal quarter results, the Agreement and Plan of Merger to acquire AccessOne Parent Holdings, Inc., and the completion of that acquisition, which made AccessOne a wholly owned subsidiary. Other 8-Ks detail the bridge loan credit agreement, amendments to its credit facility with Capital One and the voting results of its annual meeting of stockholders.
Through this page, users can also locate annual reports on Form 10-K and quarterly reports on Form 10-Q (when available in the broader filing set), which typically contain segment information for subscription and related services, payment processing fees and network solutions, along with discussions of non-GAAP measures such as Adjusted EBITDA. Proxy materials and governance-related filings provide additional context on board elections, auditor ratification and executive compensation votes.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, explain complex sections and surface items such as new debt obligations, acquisition terms or changes to credit agreements. Real-time updates from EDGAR, combined with simplified explanations, make it easier to track Phreesia’s regulatory history, capital structure and major corporate actions without reading every page of each filing.
Phreesia insider sale by SVP, Human Resources. Amy Beth VanDuyn sold 1,762 shares of Phreesia, Inc. (PHR) on 09/16/2025 at a weighted average price of $23.2844 per share. The filing shows 112,479 shares beneficially owned by the reporting person after the transaction, held directly. The sale was disclosed as a non-discretionary, mandatory sell-to-cover to satisfy tax withholding obligations related to the settlement of restricted stock units; proceeds were realized across multiple transactions at prices ranging from $22.83 to $23.69 per share. The Form 4 was signed by Power of Attorney on 09/18/2025.
Phreesia, Inc. (PHR) filed a Form 144 reporting a proposed sale of 93 common shares through Fidelity Brokerage Services with an aggregate market value of $2,226.29, slated for 09/18/2025. The filing shows those 93 shares were acquired by restricted stock vesting on 09/15/2025 (35 shares) and 09/16/2025 (58 shares) and were received as compensation. The issuer has 59,914,473 shares outstanding, so the proposed sale represents a de minimis fraction of the outstanding stock. The filing also lists multiple insider sales over the past three months, including larger transactions by David Linetsky (e.g., 23,729 shares on 06/27/2025 for $676,195.48). The notice includes the standard signer representations about absence of undisclosed material information.
Phreesia, Inc. submitted a Form 144 notice disclosing a proposed sale of 1,064 common shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $25,004.00. The filing reports 59,914,473 shares outstanding. The 1,064 shares were acquired on 09/11/2025 under a restricted stock vesting arrangement and paid as compensation. The filing also lists multiple sales by Jessica Weiss and David Linetsky during the prior three months, including larger blocks by Mr. Linetsky (e.g., 23,729 shares for $676,195.48 on 06/27/2025). The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.
Form 144 filed for Phreesia, Inc. (PHR) shows a proposed sale of 2,059 common shares through Fidelity Brokerage Services with an aggregate market value of $48,386.50 and an approximate sale date of 09/17/2025. The shares were acquired by restricted stock vesting on 09/11/2025 and were issued as compensation. The filing reports total outstanding shares of 59,914,473. The filer also disclosed sales by Alison C. Hoffman within the past three months: 1,245 shares on 07/17/2025 for $33,472.82 and 3,133 shares on 09/16/2025 for $72,950.03. The notice includes the standard attestation that the seller is unaware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filing reports a proposed sale of 940 common shares through Fidelity Brokerage Services with an aggregate market value of $21,887.34 and approximately 59,914,473 shares outstanding. The securities were acquired on 09/11/2025 through restricted stock vesting and the stated nature of payment is compensation. The filer lists an approximate sale date of 09/16/2025 on the NYSE. The filing also discloses recent open-market sales by the same person totaling 2,391 shares for $65,139.96 across trades dated 07/07/2025–07/18/2025. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filed a Form 144 reporting an intended sale of 1,762 common shares with an aggregate market value of $41,027.11, expected to occur on 09/16/2025 on the NYSE. The shares were acquired on 09/11/2025 through restricted stock vesting and were received as compensation.
The filer, identified as Amy Vanduyn, previously sold 640 shares on 07/17/2025 for $17,206.91 and 18,573 shares on 08/25/2025 for $564,055.11. The filing discloses there are 59,914,473 shares outstanding. The document includes the broker name and address (Fidelity Brokerage Services LLC) and a standard attestation that the seller is not aware of undisclosed material adverse information.
Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03. The shares were acquired on 09/11/2025 through restricted stock vesting and payment classified as compensation. The planned sale date is 09/16/2025 on the NYSE. The filer reported a prior sale within three months: 1,245 shares sold on 07/17/2025 for $33,472.82. The filing lists total outstanding shares as 59,914,473. Several standard identifying fields (issuer address, filer CIK/CCC, and named filer contact) are not provided in the visible content.
Phreesia, Inc. insider filing notifies a proposed sale of 6,328 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $147,343.68, and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 upon restricted stock vesting as compensation. The filer also reported three sales during the past three months totaling 103,164 shares for gross proceeds of $3,210,162.74 (sales on 07/17/2025, 08/27/2025 and 08/28/2025). The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 2,051 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $47,756.30 and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 as restricted stock that vested and were received as compensation. The filer certifies no undisclosed material adverse information. The filing also discloses recent open-market sales by insiders in the past three months, including large disposals by David Linetsky totaling 41,174 shares across June–August 2025 and smaller sales by Jessica Weiss.
Form 144 Notice for Phreesia, Inc. (PHR) shows a proposed sale of 114 common shares through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $2,654.42. The shares were acquired by the seller on 09/11/2025 upon restricted stock vesting and the consideration is listed as compensation. The filing reports the issuer has 59,914,473 shares outstanding. The document also lists multiple insider sales during the prior three months, including notable transactions by David Linetsky: 23,729 shares for $676,195.48 on 06/27/2025 and 17,445 shares for $518,681.81 on 08/22/2025. Other smaller sales by Jessica Weiss and additional sales by Linetsky are recorded with dates and gross proceeds. The filer certifies there is no undisclosed material adverse information known to the seller.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
